Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.
Bernardini N, Dattola A, Rossi R, Pagnanelli G, Amerio P, Atzori L, Mugheddu C, Lora V, Giordano D, Guacci LF, Persechino S, Richetta AG, Skroza N, Potenza C. Bernardini N, et al. Among authors: pagnanelli g. J Pers Med. 2024 Dec 22;14(12):1169. doi: 10.3390/jpm14121169. J Pers Med. 2024. PMID: 39728081 Free PMC article.
Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID.
Floridia M, Giuliano M, Weimer LE, Ciardi MR, Agostoni P, Palange P, Rovere Querini P, Zucco S, Tosato M, Lo Forte A, Bonfanti P, Lacedonia D, Barisione E, Figliozzi S, Andreozzi P, Damiano C, Pricci F, Onder G; I. S. S. Long-COVID Study Group. Floridia M, et al. BMC Med. 2024 Nov 14;22(1):532. doi: 10.1186/s12916-024-03746-9. BMC Med. 2024. PMID: 39543596 Free PMC article.
Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region.
Dattola A, Bernardini N, Caldarola G, Coppola R, De Simone C, Giordano D, Giunta A, Moretta G, Pagnanelli G, Panasiti V, Persechino S, Potenza C, Trovato F, Zangrilli A, Bianchi L, Pellacani G, Peris K, Richetta AG. Dattola A, et al. Among authors: pagnanelli g. Dermatol Pract Concept. 2024 Jul 1;14(3):e2024166. doi: 10.5826/dpc.1403a166. Dermatol Pract Concept. 2024. PMID: 39122514 Free PMC article.
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis.
Dattola A, Bernardini N, Anedda J, Atzori L, Bonifati C, Bruni PL, Graceffa D, Giordano D, Molinelli E, Moretta G, Mugheddu C, Offidani A, Pagnanelli G, Pallotta S, Papini M, Persechino S, Richetta AG, Tolino E, Pellacani G, Potenza C. Dattola A, et al. Among authors: pagnanelli g. Ital J Dermatol Venerol. 2024 Aug;159(4):467-469. doi: 10.23736/S2784-8671.24.07921-0. Epub 2024 Jun 3. Ital J Dermatol Venerol. 2024. PMID: 38829271 No abstract available.
Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real-world study.
Graceffa D, Zangrilli A, Caldarola G, Lora V, Orsini D, Moretta G, Pagnanelli G, Provini A, Masini C, Bavetta M, Giordano D, Richetta A, Tolino E, Bianchi L, Peris K, Sperati F, Bonifati C. Graceffa D, et al. Among authors: pagnanelli g. Int J Dermatol. 2024 Oct;63(10):1383-1391. doi: 10.1111/ijd.17156. Epub 2024 Apr 7. Int J Dermatol. 2024. PMID: 38584311
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E. Russo F, et al. Among authors: pagnanelli g. Clin Cosmet Investig Dermatol. 2023 Dec 12;16:3561-3574. doi: 10.2147/CCID.S416149. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 38107670 Free PMC article.
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study.
Caldarola G, Zangrilli A, Bernardini N, Bavetta M, De Simone C, Graceffa D, Bonifati C, Faleri S, Giordano D, Mariani M, Micheli A, Moretta G, Pagnanelli G, Panasiti V, Provini A, Richetta A, Peris K, Bianchi L. Caldarola G, et al. Among authors: pagnanelli g. Dermatol Ther. 2022 Jun;35(6):e15489. doi: 10.1111/dth.15489. Epub 2022 Apr 13. Dermatol Ther. 2022. PMID: 35385202 Free PMC article.
36 results